美国单一中毒中心报告的苯甲酸酯暴露结果:20年回顾。

IF 3.3
Corey D Cicci, Jillian Theobald, Matthew Stanton, Ryan Feldman
{"title":"美国单一中毒中心报告的苯甲酸酯暴露结果:20年回顾。","authors":"Corey D Cicci, Jillian Theobald, Matthew Stanton, Ryan Feldman","doi":"10.1080/15563650.2025.2512817","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Benzonatate is an antitussive with sodium channel blocking properties that may cause seizures, dysrhythmias, and death in overdose. Limited data describe the medical outcomes of benzonatate exposures, and no standard treatment guidelines exist for managing benzonatate toxicity. We characterized clinical outcomes and management of benzonatate exposures over a 20-year period at the Wisconsin Poison Center.</p><p><strong>Methods: </strong>This retrospective case review examined all benzonatate exposures reported to a single regional poison center from January 1, 2000 through December 31, 2019. Exposures were excluded if the medical record was incomplete. The primary outcome was the rate of serious adverse effects, defined as seizure, electrocardiogram changes, coma or central nervous system depression, or death. Potential life-saving treatments (antiepileptics, antidysrhythmics, vasopressors, sodium bicarbonate, or intravenous lipid therapy) were also assessed.</p><p><strong>Results: </strong>A total of 313 calls were received with 48 exposures excluded, leaving 265 exposures included for analysis. Most exposures were female (162/265; 61%) with a median age of 19 years (IQR: 4-39 years). Sixteen exposures were adverse reactions only. Of intentional exposures (106/265; 40%), 23 (22%) experienced at least one serious adverse effect and 40 (38%) were hospitalized. Of unintentional exposures (143/265, 54%), one (0.7%) experienced a serious adverse effect and three (2%) were hospitalized. Regarding 77 unintentional pediatric exposures, none experienced a serious adverse effect, with two (2/77; 3%) hospitalized. Two deaths (0.8%) occurred during the study period; both were intentional exposures.</p><p><strong>Discussion: </strong>While severe outcomes are possible after intentional exposures, unintentional exposures rarely exhibited serious toxicities. No therapeutic interventions beyond supportive care were consistently employed.</p><p><strong>Conclusions: </strong>Intentional exposures to benzonatate more commonly warranted significant therapeutic interventions and caused a higher incidence of serious toxicity. Unintentional exposures did not result in clinically significant adverse effects. Although benzonatate can result in serious toxicity, adults with unintentional exposures may be candidates for home management.</p>","PeriodicalId":520593,"journal":{"name":"Clinical toxicology (Philadelphia, Pa.)","volume":" ","pages":"488-494"},"PeriodicalIF":3.3000,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Outcomes of benzonatate exposures reported to a single United States poison center: a 20-year review.\",\"authors\":\"Corey D Cicci, Jillian Theobald, Matthew Stanton, Ryan Feldman\",\"doi\":\"10.1080/15563650.2025.2512817\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Benzonatate is an antitussive with sodium channel blocking properties that may cause seizures, dysrhythmias, and death in overdose. Limited data describe the medical outcomes of benzonatate exposures, and no standard treatment guidelines exist for managing benzonatate toxicity. We characterized clinical outcomes and management of benzonatate exposures over a 20-year period at the Wisconsin Poison Center.</p><p><strong>Methods: </strong>This retrospective case review examined all benzonatate exposures reported to a single regional poison center from January 1, 2000 through December 31, 2019. Exposures were excluded if the medical record was incomplete. The primary outcome was the rate of serious adverse effects, defined as seizure, electrocardiogram changes, coma or central nervous system depression, or death. Potential life-saving treatments (antiepileptics, antidysrhythmics, vasopressors, sodium bicarbonate, or intravenous lipid therapy) were also assessed.</p><p><strong>Results: </strong>A total of 313 calls were received with 48 exposures excluded, leaving 265 exposures included for analysis. Most exposures were female (162/265; 61%) with a median age of 19 years (IQR: 4-39 years). Sixteen exposures were adverse reactions only. Of intentional exposures (106/265; 40%), 23 (22%) experienced at least one serious adverse effect and 40 (38%) were hospitalized. Of unintentional exposures (143/265, 54%), one (0.7%) experienced a serious adverse effect and three (2%) were hospitalized. Regarding 77 unintentional pediatric exposures, none experienced a serious adverse effect, with two (2/77; 3%) hospitalized. Two deaths (0.8%) occurred during the study period; both were intentional exposures.</p><p><strong>Discussion: </strong>While severe outcomes are possible after intentional exposures, unintentional exposures rarely exhibited serious toxicities. No therapeutic interventions beyond supportive care were consistently employed.</p><p><strong>Conclusions: </strong>Intentional exposures to benzonatate more commonly warranted significant therapeutic interventions and caused a higher incidence of serious toxicity. Unintentional exposures did not result in clinically significant adverse effects. Although benzonatate can result in serious toxicity, adults with unintentional exposures may be candidates for home management.</p>\",\"PeriodicalId\":520593,\"journal\":{\"name\":\"Clinical toxicology (Philadelphia, Pa.)\",\"volume\":\" \",\"pages\":\"488-494\"},\"PeriodicalIF\":3.3000,\"publicationDate\":\"2025-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical toxicology (Philadelphia, Pa.)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1080/15563650.2025.2512817\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/6/13 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical toxicology (Philadelphia, Pa.)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/15563650.2025.2512817","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/6/13 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

背景:苯甲酸酯是一种具有钠通道阻断特性的止咳药,过量可引起癫痫发作、心律失常和死亡。有限的数据描述了接触苯甲酸盐的医疗结果,并且没有管理苯甲酸盐毒性的标准治疗指南。我们描述了在威斯康星州中毒中心20年期间苯甲酸酯暴露的临床结果和管理。方法:本回顾性病例回顾分析了2000年1月1日至2019年12月31日期间向单一区域毒物中心报告的所有苯甲酸盐暴露。如果医疗记录不完整,则排除暴露。主要结果是严重不良反应的发生率,定义为癫痫发作、心电图改变、昏迷或中枢神经系统抑制或死亡。还评估了可能挽救生命的治疗方法(抗癫痫药、抗心律失常药、血管加压药、碳酸氢钠或静脉脂质治疗)。结果:共收到313个电话,排除48个曝光,留下265个曝光用于分析。暴露者以女性居多(162/265;61%),中位年龄19岁(IQR: 4-39岁)。16次暴露仅为不良反应。故意曝光(106/265;40%), 23例(22%)经历了至少一次严重不良反应,40例(38%)住院。在非故意暴露(143/265,54%)中,1人(0.7%)出现严重不良反应,3人(2%)住院。在77例儿童意外暴露中,没有一例发生严重不良反应,其中2例(2/77;3%)住院。研究期间发生2例死亡(0.8%);两者都是有意暴露的。讨论:虽然有意暴露后可能出现严重后果,但无意暴露很少表现出严重的毒性。除了支持性护理外,没有其他治疗干预措施。结论:故意暴露于苯甲酸盐更普遍地需要显著的治疗干预,并引起更高的严重毒性发生率。无意暴露没有导致临床显著的不良反应。虽然苯甲酸盐可导致严重的毒性,但无意接触的成年人可能是家庭管理的候选人。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Outcomes of benzonatate exposures reported to a single United States poison center: a 20-year review.

Background: Benzonatate is an antitussive with sodium channel blocking properties that may cause seizures, dysrhythmias, and death in overdose. Limited data describe the medical outcomes of benzonatate exposures, and no standard treatment guidelines exist for managing benzonatate toxicity. We characterized clinical outcomes and management of benzonatate exposures over a 20-year period at the Wisconsin Poison Center.

Methods: This retrospective case review examined all benzonatate exposures reported to a single regional poison center from January 1, 2000 through December 31, 2019. Exposures were excluded if the medical record was incomplete. The primary outcome was the rate of serious adverse effects, defined as seizure, electrocardiogram changes, coma or central nervous system depression, or death. Potential life-saving treatments (antiepileptics, antidysrhythmics, vasopressors, sodium bicarbonate, or intravenous lipid therapy) were also assessed.

Results: A total of 313 calls were received with 48 exposures excluded, leaving 265 exposures included for analysis. Most exposures were female (162/265; 61%) with a median age of 19 years (IQR: 4-39 years). Sixteen exposures were adverse reactions only. Of intentional exposures (106/265; 40%), 23 (22%) experienced at least one serious adverse effect and 40 (38%) were hospitalized. Of unintentional exposures (143/265, 54%), one (0.7%) experienced a serious adverse effect and three (2%) were hospitalized. Regarding 77 unintentional pediatric exposures, none experienced a serious adverse effect, with two (2/77; 3%) hospitalized. Two deaths (0.8%) occurred during the study period; both were intentional exposures.

Discussion: While severe outcomes are possible after intentional exposures, unintentional exposures rarely exhibited serious toxicities. No therapeutic interventions beyond supportive care were consistently employed.

Conclusions: Intentional exposures to benzonatate more commonly warranted significant therapeutic interventions and caused a higher incidence of serious toxicity. Unintentional exposures did not result in clinically significant adverse effects. Although benzonatate can result in serious toxicity, adults with unintentional exposures may be candidates for home management.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信